AMPH — Amphastar Pharmaceuticals, Inc.

—
Nasdaq · Health Care · Pharmaceuticals · CIK 1297184 ·
Last close
$29.10
Market Cap
$1.24B
52W High
$31.00
52W Low
$16.65
ADV30
455,900
Next earnings
2026-11-05

Quarterly Fundamentals

Revenues vs Net Income (last 4 Q)

Assets vs Liabilities (last 4 Q)

PeriodRevenuesGross profitOp incomeNet incomeAssetsCashLiabilities
Sep 2026 207,608,000 99,629,000 50,773,000 37,763,000 1,711,724,000 204,588,000 897,170,000
Jun 2026 183,903,000 93,470,000 39,729,000 30,348,000 1,743,766,000 223,614,000 975,609,000
Mar 2026 171,171,000 70,322,000 13,630,000 6,420,000 1,648,162,000 170,939,000 874,771,000
Dec 2025 183,105,000 85,670,000 35,606,000 24,429,000 1,629,299,000 170,177,000 840,494,000

Cashflow TTM (yfinance, fills SEC gap)

Operating CF
$184,610,000
Investing CF
$-52,051,000
Financing CF
$-96,462,000
CapEx
$-31,718,000
Dividends Paid
—
Buybacks
$-100,071,000
EPS Diluted TTM
$1.69
As of
2026-11-08

Balance + Analyst (yfinance extras)

Retained Earnings
$703,649,000
Inventory
$179,907,000
Receivables
$147,485,000
ST Investments
$66,509,000
EBIT TTM
$128,149,000
Pretax Income TTM
$102,023,000
Interest Exp TTM
$26,126,000
Analysts
6

Yahoo Snapshot (yfinance, live)

Total Revenue
$745,787,008
EBITDA
$221,422,000
Free Cash Flow
$14,027,000
Enterprise Value
$1,676,214,912
Total Cash
$230,634,000
Total Debt
$691,689,024
Shares Out
42,648,323
Trailing EPS
$2.18
Book Value
$19.10
ROE
12.4%
ROA
6.0%
Div Yield
0.00%

Annual Trend (SEC EDGAR, last 4y)

Revenues vs Net Income (last 4y)

FY endRevenuesOp incomeNet incomeAssetsLiabilitiesEquityOp cash flow
Dec 2025 719,887,000 140,403,000 98,094,000 1,629,299,000 840,494,000 788,805,000 156,115,000
Dec 2024 731,967,000 205,419,000 159,519,000 1,577,470,000 845,172,000 732,298,000 213,386,000
Dec 2023 644,395,000 196,987,000 137,545,000 1,512,912,000 873,491,000 639,421,000 183,503,000
Dec 2022 498,987,000 107,497,000 91,386,000 741,987,000 213,329,000 528,658,000 89,181,000

TTM Snapshot

Revenues TTM
$730,019,000
NetIncome TTM
$78,547,000
OpCashFlow TTM
—
Assets (Latest)
$1,743,766,000
Forward EPS
$3.17

Max Pain — expiry 2027-03-19 (volume-derived — Yahoo OI feed degraded)

max pain strike: $20.00 · spot: $29.71 · call volume: 15 · put volume: 8
Expected Move to 2027-03-19: ±$6.85 (23.06%) — implied range $22.86 – $36.56 · ATM straddle on $30.00 strike

Peers — same industry

TickerNameMarket CapLastDaily %
AVLN Avalyn Pharma Inc. $1.24B $27.92 —
KARD Kardigan, Inc. $1.23B $13.19 —
SLN Silence Therapeutics plc $1.23B $19.80 —
GHRS GH Research PLC $1.25B $18.27 —
AAPG ASCENTAGE PHARMA GROUP INTERNATIONAL $1.23B $13.14 —

News headlines (Yahoo Finance, 1h cache)

Is Amphastar Pharmaceuticals (AMPH) Fully Priced After Strong Q3 Earnings And Q4 Guidance?
2026-11-13 04:35 · Yahoo
Amphastar Pharmaceuticals to Present at the Jefferies Global Healthcare Conference in London
2026-11-11 11:00 · Yahoo
AMPH Q3 2026 deep dive: pipeline progress and manufacturing challenges shape outlook
2026-11-10 09:25 · Yahoo
Should Earnings Beat Require Action From Amphastar Pharmaceuticals (AMPH) Investors?
2026-11-07 16:12 · Yahoo
Amphastar (AMPH) Q3 2026 Earnings Call Transcript
2026-11-06 16:28 · Yahoo
Amphastar Pharmaceuticals Inc (AMPH) Q3 2026 Earnings Call Highlights: Record Revenue of $207. ...
2026-11-06 07:20 · Yahoo
Amphastar Pharmaceuticals Q3 Earnings Call Highlights
2026-11-06 00:14 · Yahoo
Amphastar Pharmaceuticals (NASDAQ:AMPH) reports bullish Q3 2026, stock soars
2026-11-05 22:16 · Yahoo
Amphastar Pharmaceuticals (AMPH) Tops Q3 Earnings and Revenue Estimates
2026-11-05 21:45 · Yahoo
Amphastar: Q3 Earnings Snapshot
2026-11-05 21:39 · Yahoo

Recent Insider Activity

No insider activity indexed for this ticker.